U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494175) titled 'Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants' on March 16.
Brief Summary: To evaluate the absorption, metabolism and excretion after a single intravenous bolus of [14C]HRS-9190 in healthy Participants
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Male
Intervention:
DRUG: [14C] HRS-9190
[14C] HRS-9190 for injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....